Sponsors (4)
Want the plain-English version? I'll explain what this bill does.
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Adds required reporting content to subsection (c): the annual report must (1) identify significant source countries for methamphetamine that significantly affect the United States, and (2) describe the actions by the governments of those countries to combat diversion of relevant precursor chemicals and the production and trafficking of methamphetamine.
Amends 21 U.S.C. 2312 by adjusting punctuation in existing paragraphs (1) and (2) and adding new paragraphs (3) and (4) that expand the categories of foreign persons subject to sanctions to include persons who engaged in significant activities or financial transactions materially contributing to opioid trafficking (on or after enactment) and persons who received proceeds, provided significant support, or are owned/controlled by such persons.
Inserts a new paragraph (3) ('Prioritization') into subsection (a) (defining 'person of the People's Republic of China', directing the President to prioritize identification of such persons involved in shipments related to fentanyl and related items, and requiring continuation of that prioritization until a certification), redesignates the existing paragraphs (3) and (4) as (4) and (5), respectively, and amends subsection (c) by replacing the phrase 'the date that is 5 years after such date of enactment' with 'December 31, 2030'.
Amends 22 U.S.C. 2291h(a) to change the annual report deadline from March 1 to June 1 and to replace the text in paragraph (8)(A)(i) beginning with 'pseudoephedrine' through the following text with 'chemicals)'.
Changes U.S. drug‑policy reporting and expands sanction authorities to target international fentanyl and synthetic‑opioid trafficking. It moves an annual report deadline, requires new unclassified reports (with classified annexes) and briefings on PRC‑linked trafficking and DEA presence in Chinese cities, prioritizes identification and designation of PRC persons and entities for sanctions, broadens the kinds of conduct that can trigger designations, allows sanctioning of foreign government subunits and senior officials that materially support trafficking, and adds an annual requirement to identify major methamphetamine source countries and their anti‑diversion efforts.
Amends the timing language in the matter preceding paragraph (1) of Section 489(a) of the Foreign Assistance Act of 1961 by striking "March 1" and inserting "June 1" (changes the report due date).
Amends paragraph (8)(A)(i) of Section 489(a) by striking the word "pseudoephedrine" and all that follows through and inserting the text "chemicals)" (shortens/replaces the listed text about certain chemicals).
Defines the term “appropriate committees of Congress” and lists four sub-items (A)–(D) but the specific committee names are not provided in this text.
Defines the term “DEA” to mean the Drug Enforcement Administration.
Defines the term “PRC” to mean the People’s Republic of China.
Who is affected and how:
U.S. executive branch agencies: The Department of State and Department of Justice (including the Attorney General) must prepare an expanded unclassified report with a classified annex and deliver a classified briefing; the DEA is explicitly referenced for potential overseas offices (Shanghai, Guangzhou) and will be involved in implementation and enforcement activities. These requirements increase workload for investigations, intelligence sharing, legal review, and interagency coordination.
People and entities in and linked to the People’s Republic of China: The bill directs a sustained prioritization of identification and sanctioning of PRC persons and entities involved in manufacture, shipment, financing, or facilitation of fentanyl and related substances. PRC‑based manufacturers, exporters, logistics providers, and intermediaries—plus foreign subsidiaries and affiliates—face higher designation risk, which can lead to asset freezes, U.S. sanctions, and transaction restrictions.
Foreign governments and their subdivisions/agencies: The President may now impose sanctions on foreign government instrumentalities or senior officials found to have knowingly provided material, financial, or technological support for opioid trafficking. That raises diplomatic and policy stakes for countries whose agencies are implicated.
Financial institutions and trade intermediaries: Banks, remitters, freight brokers, chemical distributors, and others handling proceeds, payments, or shipments tied to designated trafficking streams may face compliance, reporting, and counterparty‑risk consequences; enhanced due diligence and sanctions screening are likely.
Chemical and precursor suppliers, manufacturers, and equipment vendors: Companies that supply precursor chemicals, synthetic pathways, or production equipment potentially implicated in diversion or trafficking face elevated scrutiny and possibility of being designated when knowingly linked to trafficking.
U.S. public health and law‑enforcement outcomes: The legislation seeks to strengthen tools to disrupt supply chains feeding the domestic opioid crisis by tightening identification and sanction authorities and improving intelligence and diplomatic efforts, which could produce long‑term enforcement gains but also risk diplomatic friction with targeted countries.
Other countries identified as methamphetamine source nations: Governments placed on the new annual methamphetamine report will be publicly described regarding their anti‑diversion and counter‑trafficking steps, which could affect bilateral engagement, assistance, or pressure to strengthen controls.
Overall, the bill reallocates investigative and diplomatic effort toward PRC‑linked actors and broadens statutory sanction bases, increasing legal and compliance risks for foreign companies, government entities, and intermediaries tied to synthetic opioid supply chains while imposing new reporting tasks on U.S. agencies.
Expand sections to see detailed analysis
Read twice and referred to the Committee on Foreign Relations.
Introduced March 5, 2025 by James Risch · Last progress March 5, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 54.
Committee on Foreign Relations. Reported by Senator Risch without amendment. Without written report.
Committee on Foreign Relations. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on Foreign Relations.